Ratings by Lucid Capital Markets (Alex Nowak)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/28/2026 | LENSAR Inc. | LNSR | New Coverage | Buy (N/A) |
6.92 (6.45) |
-6.79% | Details | |
| 9/2/2026 | Xtant Medical | XTNT | New Coverage | Buy (N/A) |
0.37 (0.32) |
-13.51% | Details | |
| 8/24/2026 | Insight Molecular Diagnostics Inc. | IMDX | New Coverage | Buy (N/A) |
4.34 (3.28) |
-24.42% | Details | |
| 7/27/2026 | Envoy Medical | COCH | New Coverage | Buy (N/A) |
0.66 (0.66) |
0% | Details | |
| 6/3/2026 | SS Innovations Int'l | SSII | New Coverage | Buy (N/A) |
4.01 (2.63) |
-34.41% | Details | |
| 6/3/2026 | Microbot Medical | MBOT | New Coverage | Buy (N/A) |
2.01 (1.07) |
-46.77% | Details | |
| 6/3/2026 | Adagio Medical Holdings | ADGM | New Coverage | Buy (N/A) |
0.78 (0.13) |
-83.33% | Details |
